VDAC1 and neoplasm: Tumour treatment with si-RNA against human (h) VDAC1 resulted in rewired metabolism, inhibited cell proliferation, epithelial-mesenchymal transition (EMT), invasion, angiogenesis and stemness, while leading to tumour cell differentiation into neuronal-like cells [21].